Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressive therapy for severe chronic uveitis.

R H Andrasch, B Pirofsky, R P Burns

    Archives of Ophthalmology (Chicago, Ill. : 1960)
    |February 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Incineration of hazardous wastes.

    Environmental monitoring and assessment·2013
    Same author

    Clinical research during surgery residency: the Chattanooga approach.

    Current surgery·2005
    Same author

    Stereotactic breast biopsy: a study of first core samples.

    The American surgeon·2001
    Same author

    Twelve-year experience with the Thow long intestinal tube: a means of preventing postoperative bowel obstruction.

    The American surgeon·2001
    Same author

    Granulosa cell tumor in a guinea pig.

    Journal of the American Veterinary Medical Association·2001
    Same author

    The evaluation of subatmospheric pressure and hyperbaric oxygen in ischemic full-thickness wound healing.

    The American surgeon·2001

    Low-dose prednisone combined with cytotoxic immunosuppressants effectively treated severe chronic uveitis unresponsive to steroids. This therapy achieved quiescence or significant reduction in inflammation with infrequent adverse effects in all patients.

    Area of Science:

    • Ophthalmology
    • Immunosuppression Therapy

    Background:

    • Chronic uveitis is an inflammatory eye condition often resistant to standard corticosteroid treatments.
    • Severe, progressive cases require alternative therapeutic strategies to prevent vision loss.

    Purpose of the Study:

    • To evaluate the efficacy and safety of low-dose prednisone combined with cytotoxic immunosuppressive agents for chronic uveitis.
    • To assess the long-term therapeutic outcomes in patients refractory to corticosteroid monotherapy.

    Main Methods:

    • A cohort of 25 patients with severe chronic uveitis received daily low-dose prednisone (10-15 mg).
    • This was combined with either azathioprine (2.0-2.5 mg/kg) or chlorambucil (6-8 mg) as a long-term treatment regimen.
    • Patient response and adverse events were monitored.

    Related Experiment Videos

    Main Results:

    • All 25 patients demonstrated a therapeutic response to the combined therapy.
    • Complete remission of uveitis (quiescence) was achieved in 18 patients (72%).
    • The remaining seven patients (28%) experienced a significant reduction in inflammatory activity.

    Conclusions:

    • Combination therapy with low-dose prednisone and cytotoxic immunosuppressants is a viable and effective treatment for severe chronic uveitis.
    • This approach offers a favorable risk-benefit profile, with infrequent adverse side effects, for steroid-unresponsive cases.
    • Long-term management with these agents can lead to sustained control of intraocular inflammation.